Wound healing is the evolutionarily conserved, multi-phase process of tissue repair following injury, consisting of four overlapping but temporally distinct stages: hemostasis (immediate), inflammation (0-3 days), proliferation (3-21 days), and remodeling (21 days-2 years). This process involves precise spatiotemporal coordination between leukocytes, resident tissue cells (fibroblasts, keratinocytes, endothelial cells), Neurotrophic Factors, and Specialized pro-resolving mediators (SPMs), with success dependent on active termination of inflammation rather than passive decay.
Imagine wound healing as a construction site after a building collapse. Phase 1 (Hemostasis) is the emergency crew throwing up scaffolding and tarps to stop the bleeding pipes and secure the perimeter—platelets form a fibrin clot "tarp" while releasing the first emergency messages (growth factors). Phase 2 (Inflammation, 0-3 days) is the demolition team: neutrophil workers arrive in hard hats with sledgehammers (Matrix metalloproteinases (MMPs)) and blowtorches (Reactive Oxygen Species), clearing debris, broken bricks, and contaminated materials. Yes, it's loud, messy, and painful—that's PGE2 setting off alarm bells to keep people away from the danger zone. By day 3, the foreman calls in the transition crew (M2 macrophages), who sweep up, measure the space, and order new materials (collagen, growth factors). Phase 3 (Proliferation, 3-21 days) is active reconstruction: carpenters (Fibroblasts) lay down quick scaffolding beams (Collagen III) first, then switch to load-bearing steel (Collagen I). Electricians (angiogenesis via VEGF) rewire the building with new power lines (blood vessels). Phase 4 (Remodeling, 21 days-2 years) is the finishing crew: contractors (Lysyl oxidase) weld the steel beams together with cross-links, and interior designers (myofibroblasts) shrink the space to make it tighter and more efficient. The key insight: if you fire the demolition team too early (with NSAIDs) or prevent them from leaving (failed resolution), the building never gets rebuilt properly—you end up with a condemned structure (chronic wound, chronic pain).
Vascular injury → platelet adhesion to exposed collagen via Collagen receptor signaling → platelet activation → release of ADP, thromboxane A2, serotonin → platelet aggregation → thrombin generation → fibrinogen → fibrin clot formation. Simultaneously, platelets degranulate α-granules releasing PDGF, TGF-beta, VEGF, EGF, creating a provisional wound matrix.
Early (0-24 hours):
- Fibrin clot + tissue damage → DAMPs release (HMGB1, ATP, heat shock proteins)
- DAMPs bind TLR4, TLR2 on resident macrophages, mast cells
- Mast cells degranulate → histamine → vasodilation, increased permeability
- Resident macrophages → TNF-α, IL-1β, IL-6 → hepatic acute phase response
- Prostaglandins synthesis: Phospholipase A2 → arachidonic acid → COX-2 → PGE2 → peripheral sensitization via TRPV1, TRPA1 channels on nociceptors → pain and protective swelling
- Chemokine gradient: IL-8 (CXCL1), MCP-1 (CCL2), LTB4 → neutrophil chemotaxis from circulation
Mid (24-48 hours):
Late (48-72 hours):
- Apoptotic neutrophil → phosphatidylserine exposure → "eat-me" signals
- Monocyte recruitment via MCP-1 → differentiate to macrophages
- Efferocytosis: macrophages engulf apoptotic neutrophils → switch from M1 macrophages (pro-inflammatory: TNF-α, IL-12, Nitric Oxide via iNOS) to M2 macrophages (pro-resolution: IL-10, TGF-beta, Arginase)
- Omega-3 fatty acids (EPA, DHA) → 15-LOX, 5-LOX → Resolvins (RvD1, RvD2, RvE1), Protectins (PD1), Maresins (MaR1) → bind ALX-FPR2 receptor, DRV1 receptor → active termination of inflammation, enhanced efferocytosis, reduced neutrophil recruitment
graph TD
A[Tissue Injury] --> B[Platelet Activation]
B --> C["Fibrin Clot + Growth Factors"]
A --> D[DAMPs Release]
D --> E[TLR4 Activation on Macrophages]
E --> F["TNF-α, IL-1β, IL-6"]
F --> G[Neutrophil Recruitment 0-48h]
G --> H["ROS + MMP Release"]
H --> I[Debris Clearance]
G --> J[Neutrophil Apoptosis 48-72h]
J --> K[Efferocytosis by Macrophages]
K --> L["M1 → M2 Macrophage Switch"]
L --> M["IL-10, TGF-β, SPM Production"]
M --> N["Resolution + Proliferation Phase"]
O[Omega-3 FA] --> P[15-LOX, 5-LOX]
P --> Q[Resolvins, Protectins, Maresins]
Q --> L
Granulation Tissue Formation:
ECM Synthesis:
- Fibroblasts → procollagen synthesis (requires vitamin C as cofactor for prolyl and lysyl hydroxylases)
- Procollagen → collagen triple helix → secretion → Collagen III deposition
- Transition (day 7+): Collagen III → Collagen I (more tensile strength)
- Proteoglycans, fibronectin, hyaluronic acid deposition → ECM scaffolding
- Collagen I:Collagen III ratio increases from 1:1 to 4:1
- Lysyl oxidase (requires Copper) → collagen cross-linking via aldehyde formation → covalent bonds between collagen fibrils
- Matrix metalloproteinases (MMPs) (MMP-1, MMP-2, MMP-13) → collagen turnover, realignment along tension lines
- Myofibroblast-mediated contraction reduces wound size by 40-80%
- Myofibroblast apoptosis (if successful healing) → scar maturation
- Capillary regression → avascular scar tissue
- Tensile strength reaches maximum 80% of original tissue (never 100%)
Failed Resolution Markers:
Wound healing is the clinical proof-of-concept for the cPNI paradigm that acute inflammation is protective, not pathological. Standard medical practice—early NSAID administration for pain and swelling—directly impairs phases 2 and 3, delaying healing by 25-30% and increasing re-injury risk by similar margins. This is evolutionary mismatch: acute inflammatory response signals (pain via PGE2, swelling, heat) evolved as immobilization cues to prevent further tissue damage during repair. Modern intervention to "return to function quickly" bypasses this evolutionary wisdom.
Relevant Patient Populations:
- Acute musculoskeletal injuries (sprains, strains, contusions)
- Post-surgical wounds
- Chronic wounds (diabetic ulcers, pressure ulcers)—represent failed resolution with persistent M1 phenotype
- Fibromyalgia, chronic pain patients—often have history of impaired acute healing
- Athletes with recurrent injuries—frequently NSAID users during acute phase
- Autoimmune connective tissue disorders (rheumatoid arthritis, Systemic lupus erythematosus)—impaired SPM production
Metamodel Connections:
- Metamodel 1 (Bonding/Safety): Chronic wounds correlate with social isolation and low oxytocin—impaired wound healing in loneliness models shows 24% slower closure
- Metamodel 2 (Chronic Stress): Cortisol >20 μg/dL suppresses Fibroblasts collagen synthesis and impairs M1→M2 macrophage transition
- Metamodel 5 (Diet): Omega-3 fatty acids are SPM substrates—omega-3 index <4% predicts poor wound healing; vitamin C <100 mg/day impairs collagen synthesis; Zinc <8 mg/day reduces healing rate 40-50%
Clinical Thresholds:
- IL-6 >10 pg/mL at day 7 post-injury indicates failed resolution
- CRP should decrease by 50% between day 2 and day 5; persistent elevation suggests chronic inflammation
- Omega-3 index target: >8% for optimal SPM production
- Serum vitamin C: >50 μmol/L (11.4 mg/L); healing impairment below 28 μmol/L
- Zinc: serum >70 μg/dL; RBC zinc >10 μg/g Hb
Intervention Implications:
- Avoid early NSAIDs (first 48-72 hours)—use ice, compression, elevation for symptom management
- Support inflammation resolution, not suppression: omega-3 FA (EPA 2-3g/day + DHA 1-2g/day), vitamin C (1-2g/day during healing), Zinc (30-50mg/day elemental), Curcumin (as resolution enhancer, not suppressant)
- Proteolytic enzymes (Bromelain 500mg 3x/day, Serrapeptase) support debris clearance without blocking prostaglandin synthesis
- Movement paradox: Early gentle movement supports lymphatic drainage and prevents stiffness, but avoid loading tissue before Collagen I dominance (typically day 7-10)
- Hyperbaric oxygen, Photobiomodulation enhance angiogenesis in proliferation phase
- Address failed resolution: if wound >3 weeks, assess for diabetes, zinc deficiency, protein malnutrition, chronic stress, social isolation
- neutrophil infiltration peaks at 24-48 hours post-injury; premature suppression with NSAIDs delays healing by 1-2 days and increases infection risk
- M1→M2 macrophage switch occurs at 72-96 hours; this transition is SPM-dependent and marks inflammation-to-proliferation boundary
- Collagen III (thin, flexible fibrils) peaks at day 5-7, providing 20-30% original tensile strength
- Collagen I (thick, load-bearing fibrils) begins deposition day 7, dominates by day 14, reaches maximum at 60 days
- Tensile strength reaches only 80% of pre-injury levels even after complete remodeling (12-24 months)—scar tissue is permanently weaker
- Early NSAID use (first 48 hours) reduces Collagen biosynthesis pathway by 30-40% and impairs bone fracture healing
- vitamin C >100 mg/day required for collagen hydroxylation; scurvy-level deficiency (<10 mg/day) causes wound dehiscence
- Zinc deficiency (<8 mg/day) reduces epithelialization rate by 40-50% and impairs keratinocyte migration
- SPM levels (RvD1, MaR1) peak during resolution phase (days 3-7); absence predicts chronic wound formation
- Chronic wounds show 5-10x higher IL-1β:IL-10 ratio, absent M1→M2 transition, and undetectable SPM levels
- Diabetic wounds: AGEs cross-link collagen abnormally, reducing Matrix metalloproteinases (MMPs) activity and preventing remodeling
- Omega-3 index <4% associated with 50% slower wound closure in surgical patients; >8% optimal
- Cortisol >15 μg/dL chronically reduces TGF-beta sensitivity in fibroblasts via Glucocorticoid Receptor downregulation
- Myofibroblast persistence beyond day 21 indicates pathological fibrosis (keloid, hypertrophic scar)
- Lysyl oxidase requires Copper as cofactor; copper deficiency causes weak, non-cross-linked collagen (connective tissue fragility)
- acute inflammatory response — protective phase 2 of wound healing; suppression delays repair and increases chronic pain risk
- inflammation — phase 2 of healing cascade; must be actively resolved, not merely suppressed
- resolution — active termination of inflammation via SPMs; failure leads to chronic wounds and fibrosis
- neutrophils — first responders (24-48h) clearing debris via Reactive Oxygen Species and MMPs; apoptosis triggers M1→M2 switch
- macrophages — orchestrate phase transition: M1 macrophages clear debris (day 0-3), M2 macrophages drive proliferation (day 3+)
- M1 macrophages — pro-inflammatory phenotype secreting TNF-α, IL-12, Nitric Oxide; essential for debris clearance but must transition
- M2 macrophages — pro-resolution phenotype secreting IL-10, TGF-beta, VEGF; drive proliferation and angiogenesis
- Specialized pro-resolving mediators (SPMs) — lipid mediators (resolvins, protectins, maresins) actively terminate inflammation and enhance efferocytosis
- Resolvins — omega-3-derived SPMs (RvD1, RvD2, RvE1) binding ALX-FPR2 receptor to stop neutrophil recruitment and promote M2 polarization
- Protectins — DHA-derived SPMs (PD1, NPD1) enhancing efferocytosis and reducing pro-inflammatory gene expression
- Maresins — macrophage-derived SPMs (MaR1, MaR2) promoting tissue regeneration and pain resolution
- Prostaglandins — PGE2 mediates protective pain and swelling via TRPV1, EP4 receptors; also switches to pro-resolution at low concentrations
- PGE2 — dual-phase mediator: high concentration (early) = pain/inflammation; low concentration (late, with SPMs) = resolution enhancement
- Efferocytosis — macrophage engulfment of apoptotic neutrophils; triggers M1→M2 switch and SPM synthesis
- Fibroblasts — synthesize collagen (III→I transition), deposit ECM, differentiate to myofibroblasts for contraction
- Collagen III — first collagen deposited (day 5-7); thin fibrils provide provisional strength (20-30% original)
- Collagen I — mature load-bearing collagen (day 7+); thick fibrils provide final strength (max 80% original)
- Collagen biosynthesis pathway — requires vitamin C (hydroxylation), Zinc (collagenase activity), copper (Lysyl oxidase cross-linking)
- Matrix metalloproteinases (MMPs) — remodel ECM during proliferation and remodeling; MMP-1, -2, -8, -9, -13 degrade and realign collagen
- Lysyl oxidase — copper-dependent enzyme creating covalent collagen cross-links for tensile strength
- myofibroblasts — contractile cells expressing α-smooth muscle actin; reduce wound size 40-80% during remodeling
- angiogenesis — VEGF-driven new blood vessel formation essential for nutrient delivery to healing tissue
- VEGF — vascular endothelial growth factor from macrophages, keratinocytes; drives endothelial proliferation and capillary formation
- TGF-beta — master growth factor: recruits fibroblasts, induces collagen synthesis, drives myofibroblast differentiation
- NSAIDs — COX-2 inhibitors that block PGE2 synthesis; premature use (day 0-3) impairs neutrophil function, delays healing 25-30%
- vitamin C — cofactor for prolyl and lysyl hydroxylases in collagen triple-helix formation; deficiency causes wound dehiscence
- Zinc — cofactor for MMPs, collagen synthesis, keratinocyte migration; deficiency reduces healing rate 40-50%
- Omega-3 fatty acids — EPA/DHA substrates for SPM synthesis via 15-LOX, 5-LOX; index >8% optimal for resolution
- chronic pain — impaired wound healing and failed resolution increase risk via persistent inflammatory signaling and central sensitization
- central sensitization — prolonged inflammatory input from non-resolving wounds drives central nervous system amplification
- Reactive Oxygen Species — controlled ROS from neutrophils aid pathogen killing and debris oxidation; excess (e.g., diabetes) impairs healing
- Cortisol — chronic elevation >15 μg/dL suppresses fibroblast collagen synthesis and impairs M1→M2 transition via GR signaling
- IL-6 — dual-phase cytokine: early (pro-inflammatory neutrophil recruitment); late (with IL-10, pro-resolution and tissue repair)
- IL-10 — anti-inflammatory cytokine from M2 macrophages; suppresses TNF-α, IL-1β, promotes resolution
- TNF-α — early pro-inflammatory signal recruiting neutrophils; persistence indicates failed M1→M2 switch
- oxidative stress — balanced ROS essential for debris clearance; excessive ROS (hyperglycemia, smoking) impairs angiogenesis and collagen synthesis
- Copper — essential cofactor for Lysyl oxidase; deficiency causes weak, non-cross-linked collagen (Ehlers-Danlos-like fragility)
- chronic inflammation — failed wound healing with persistent M1 macrophages, absent SPMs, and continuous tissue breakdown
- diabetes — AGEs impair collagen remodeling, chronic hyperglycemia reduces neutrophil function and VEGF signaling
- Curcumin — dual-phase modulator: low-dose enhances SPM synthesis and resolution; high-dose (>1g) may suppress necessary acute inflammation
- Bromelain — proteolytic enzyme supporting debris clearance without COX-2 inhibition; enhances neutrophil apoptosis and efferocytosis
- Module 1
- Module 2
- Module 5